期刊
BIOTECHNOLOGY JOURNAL
卷 18, 期 9, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.202300143
关键词
high-sensitivity paper analytical device; lateral flow test; point-of-care diagnostics; quantitative multi-step assay; smartphone colorimetric readout; vertical flow mu PAD
This paper presents a paper-based microfluidic device, called MEL-PAD, which can perform enzyme-linked assays. The MEL-PAD system utilizes a wash-free sandwich coupling and vertical flow to detect analytes. It achieves efficient washing and color change detection using nitrocellulose and a chromogenic substrate. The MEL-PAD demonstrates high sensitivity and versatility for quantifying various analytes. The article also shows the potential of MEL-PAD in detecting DNA from Staphylococcus epidermidis.
A paper microfluidic device capable of conducting enzyme-linked assays is presented: a microfluidic enzyme-linked paper analytical device (MEL-PAD). The system exploits a wash-free sandwich coupling to form beads/analyte/enzyme complexes, which are subsequently added to the vertical flow device composed of wax-printed paper, waxed nitrocellulose membrane and absorbent/barrier layers. The nitrocellulose retains the bead complexes without disrupting the flow, enabling for an efficient washing step. The entrapped complexes then interact with the chromogenic substrate stored on the detection paper, generating a color change on it, quantified with an open-source smartphone software. This is a universal paper-based technology suitable for high sensitivity quantification of many analytes, such as proteins or nucleic acids, with different enzyme-linked formats. Here, the potential of the MEL-PAD is demonstrated to detect DNA from Staphylococcus epidermidis. After generation of isothermally amplified genomic DNA from bacteria, Biotin/FITC-labeled products were analyzed with the MEL-PAD, exploiting streptavidin-coated beads and antiFITC-horseradish peroxidase. The MEL-PAD achieved a limit of detection (LOD) and quantification <10 genome copies/ML, these being at least 70-and 1000-fold lower, respectively, than a traditional lateral flow assay (LFA) exploiting immobilized streptavidin and antiFITC-gold nanoparticles. It is envisaged that the device will be a good option for low-cost, simple, quantitative, and sensitive paper-based point-of-care testing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据